13 November 2023
13 November 2023
At the FT Global Pharma and Biotech Summit in London, various industry players shared their thoughts on technological and regulatory advancements.
The trial is carried out at the International Center for Lysosomal Disorders of the University Hospital of Hamburg Eppendorf.
The company started the study at the Tel Aviv Sourasky Medical Center.
Progression-free survival is the primary endpoint of the trial.
At the BIO-Europe conference, experts discussed remaining challenges in AI healthcare interventions.
The trial will assess the safety of unilateral subretinal administration of OCU410ST in patients with Stargardt disease.
The Clinical Trials Arena team also review assets in oncology, infectious diseases and cariology.
The US-based company has set aside the funding to bolster clinical support investigating the therapy in CD5-positive patients.
Merging industry-leading business intelligence & award-winning journalism, this is an unrivalled opportunity for engagement with B2B professionals across a network of 40+ leading media websites.
Steer your business strategy with key data and insights from our latest market research reports and company profiles. Not ready to buy? Start small by downloading a sample report first.
Give your business an edge with our leading industry insights.
